An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

Illana Gozes, Susan McCune, Lauren Jacobson, +4

Journal of Pharmacology and Experimental Therapeutics

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

Terry W. Moody, Farah Zia, Muriel Draoui, +4

Proceedings of the National Academy of Sciences

Tumor BiologyOncologyLung InflammationMedicineOncogenic Agent +12

Bomebesin: specific binding to rat brain membranes.

Terry W. Moody, Candace B. Pert, J. Rivier, +1

Proceedings of the National Academy of Sciences

Synaptic TransmissionNeurotransmitterSocial SciencesRadiolabeled Bomebesin AnalogueNeurochemistry +14

Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung

Louis Y. Korman, D. N. Carney, Marc L. Citron, +1

Lung Cancer

MedicinePathologyPeptide TherapeuticPeptide ScienceLung Cancer +3

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.

H. Zia, Toyoaki Hida, Sonia B. Jakowlew, +6

PubMed

Breast Cancer GrowthBreast OncologyEndocrine-related CancerMedicineImmunology +11

Distribution of bombesin binding sites in the rat gastrointestinal tract

Timothy H. Moran, Terry W. Moody, Anne M. Hostetler, +3

Peptides

BiochemistryMedicineRat Gastrointestinal TractGastroenterologyToxicology +3

Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells.

Farah Zia, Mirela O. Fágárásan, Kenan Bitar, +4

PubMed

ImmunologyCell ProliferationCancer BiologyCellular PhysiologyTumor Biology +20

Blockade of brain bombesin/GRP receptors increases food intake in satiated rats

Z. Merali, Terry W. Moody, D. H. Coy

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

NutritionFood IntakeSatiety ResearchSatiated RatsBrain Bombesin/grp Receptors +19

PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells

Julius Leyton, Yehoshua Gozes, Joseph R. Pisegna, +5

Breast Cancer Research and Treatment

Molecular PharmacologyBreast OncologyMedicineBreast Cancer CellsReceptor (Biochemistry) +5

High affinity binding of VIP to human lung cancer cell lines

Margaret M. Shaffer, D N Carney, Louis Y. Korman, +2

Peptides

Oncogenic AgentMedicineHigh Affinity BindingReceptor (Biochemistry)Tumor Targeting +5